Smallwood Wealth Investment Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EPGL
RG
SAM
CDDEC
MGP
Smallwood Wealth Investment Management's AZN Position: Q2 2026 in Review
Smallwood Wealth Investment Management held its AstraZeneca (AZN) position steady in Q2 2026 at 71 shares worth $13.5K. The position accounts for 0.01% of the portfolio, ranked #307.
Smallwood Wealth Investment Management first reported a position in AZN in Q1 2025 and has held it in 6 quarters since. The position peaked at $20.8K in Q1 2025. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Smallwood Wealth Investment Management held 71 shares of AstraZeneca worth $13.5K as of Q2 2026.
- Smallwood Wealth Investment Management left its AstraZeneca share count unchanged in Q2 2026.
- AstraZeneca made up 0.01% of Smallwood Wealth Investment Management's portfolio in Q2 2026, its #307 holding.
- Smallwood Wealth Investment Management first reported a position in AstraZeneca in Q1 2025 and has held it in 6 quarters since.
- Smallwood Wealth Investment Management's AstraZeneca position peaked at $20.8K in Q1 2025.
- 906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Smallwood Wealth Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.